Traditional method of drug discovery is time consuming
R&D Focus
AI-enabled drug and disease discovery platform
Innovative Solution
Metanovas provides a drug and disease discovery platform empowered by machine learning and AI to discover novel disease targets, screen for potential drugs, repurpose existing drugs for new indication
Solution Effectiveness
Metanovas Ai enabled drug discovery platform results in 45% more success in R&D
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
$1.57M
Last Funding Amount
$1.57M
Startup Stage
Early Stage
Lead Investors
Redhill Capital, Sinopharm Capital
People
Founders
Meijie Wang
CEO
Meijie Wang
About
Metanovas is a provider of an AI-enabled drug and disease discovery platform
